Kary Eldred
Director at Galectin Therapeutics · 3 reported transactions in 1 company · latest trade Feb 6, 2026
Their record
Across their whole record, 2 purchases can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +15.0%, S&P 500 +10.4% over the same days.
Their trades
Bought | Feb 6, 2026 | Feb 6, 2026 close $2.80 → Oct 28, 2026 close $3.54. S&P 500 +11.4% over the same days. | ||
Bought | Dec 23, 2025 | Dec 23, 2025 close $3.99 → Oct 28, 2026 close $3.54. S&P 500 +11.9% over the same days. | ||
Bought | Jul 21, 2025 | Jul 21, 2025 close $2.74 → Oct 28, 2026 close $3.54. S&P 500 +22.4% over the same days. |
BoughtGalectin Therapeutics
$810.00
Feb 6, 2026 close $2.80 → Oct 28, 2026 close $3.54. S&P 500 +11.4% over the same days.
BoughtGalectin Therapeutics
$2.6K
Dec 23, 2025 close $3.99 → Oct 28, 2026 close $3.54. S&P 500 +11.9% over the same days.
BoughtGalectin Therapeutics
$2.9K
Jul 21, 2025 close $2.74 → Oct 28, 2026 close $3.54. S&P 500 +22.4% over the same days.